The pharmacokinetics pck of ceftizoxime in infants 1 6 months of age
Reed, M.D.; Gooch, W.M.IIi; Swenson, E.; Blumer, J.L.
Clinical Pharmacology and Therapeutics 43(2): 155
1988
ISSN/ISBN: 0009-9236 Accession: 029392921
Full Text Article emailed within 1 workday: $29.90
Related References
Reed, M.D.; Gooch, W.M.; Minton, S.D.; Tanaka-Kido, J.; Santos, J.I.; Yamashita, T.S.; Blumer, J.L. 1991: Ceftizoxime disposition in neonates and infants during the first six months of life Dicp: the Annals of PharmacoTherapy 25(4): 344-347Karna, P.; Carrizales, E.; Dolanski, E.A.; Kumar, A.; Dyke, J. 1990: Pharmacokinetics pmk of ceftizoxime in premature infants Pediatric Research 27(4 Part 2): 60A
Nakamura, C.; Higashi, A.; Ikeda, T.; Iribe, K.; Inotsume, N.; Nakano, M.; Matsuda, I. 1990: Pharmacokinetics of ceftizoxime in preterm and term infants Developmental Pharmacology and Therapeutics 14(1): 69-70
Karna, P.; Lee, C.; Kumar, A.; Dyke, J.; Gooch, W.M. 1993: Population pharmacokinetics of ceftizoxime in premature infants Clinical Pharmacology and Therapeutics 53(2): 184
Toyonaga, Y.; Sugita, M.; Hori, M. 1988: Pharmacokinetics and clinical studies of ceftizoxime in newborn and premature infants Japanese Journal of Antibiotics 41(8): 1065-1086
McCann, M E.; Sethna, N F.; Mazoit, J X.; Sullivan, L J.; Berde, C B. 2000: Room H, 10/16/2000 2: 00 PM - 4: 00 PM (PS) Pharmacokinetics of Lumbar Epidural Ropivacaine in Infants and Toddlers, Ages 3 Months to 48 Months Anesthesiology 93(Suppl): A-1262
Patamasucon, P.; Kaojarern, S.; Kusmiesz, H.; Nelson, J.D. 1981: Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age Antimicrobial Agents and ChemoTherapy 19(5): 736-739
Sáez-Llorens, X.; Macias, M.; Maiya, P.; Pineros, J.; Jafri, H.S.; Chatterjee, A.; Ruiz, G.; Raghavan, J.; Bradshaw, S.K.; Kartsonis, N.A.; Sun, P.; Strohmaier, K.M.; Fallon, M.; Bi, S.; Stone, J.A.; Chow, J.W. 2009: Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age Antimicrobial Agents and ChemoTherapy 53(3): 869-875
Weber, M.W.; Gatchalian, S.R.; Ogunlesi, O.; Smith, A.; McCracken, G.H.; Qazi, S.; Weber, A.F.; Olsen, K.; Mulholland, E.K. 1999: Chloramphenicol pharmacokinetics in infants less than three months of age in the Philippines and The Gambia Pediatric Infectious Disease Journal 18(10): 896-901
Boucher F.D.; Au D.S.; Martin D.M.; Inguillo D.; Blum R.; Lafon S.; Arvin A.M.; Prober C.G. 1989: Pharmacokinetics and safety of azidothymidine azt in infants less than three months old exposed at birth to hiv Clinical Research 37(1): 190A
Jacqz Aigrain, E.; Faure, C.; Michaud, L.; Popon, M.; Turck, D.; Navarro, J. 2000: Intravenous omeprazole in infants less than 30 months And effect on 24-h intragastric pH and pharmacokinetics Fundamental and Clinical Pharmacology 14(3): 263
Zhao, W.; Hill, H.; Le Guellec, C.; Neal, T.; Mahoney, S.; Paulus, S.; Castellan, C.; Kassai, B.; van den Anker, J.N.; Kearns, G.L.; Turner, M.A.; Jacqz-Aigrain, E. 2014: Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age Antimicrobial Agents and ChemoTherapy 58(11): 6572-6580
Chalkiadis, G.A.; Anderson, B.J.; Tay, M.; Bjorksten, A.; Kelly, J.J. 2005: Pharmacokinetics of levobupivacaine after caudal epidural administration in infants less than 3 months of age British Journal of Anaesthesia 95(4): 524-529
Sidhu, J.; Bullman, J.; Onks, D.; Caldwell, P.; Messenheimer, J. 2002: Preliminary population pharmacokinetics of lamotrigine in infants aged 1-24 months Epilepsia 43(Suppl 7): 108
Faure, C.; Michaud, L.; Popon, M.; Turck, D.; Navarro, J.; Jacqz Aigrain, E. 2000: Intravenous omeprazole in infants less than 30 months Effect on 24-hour intragastric pH and pharmacokinetics JPGN 31(Suppl 2): S130